Hatice Ceren Ates
Hat mitgewirkt an:
-
Impedimetric immunosensor for on-site measurement of Rituximab from invasive and non-invasive samples
-
Designing electrochemical microfluidic multiplexed biosensors for on-site applications
-
On-site therapeutic drug monitoring
-
Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management